Prosecution Insights
Last updated: October 04, 2026

Giordano Law LLC

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

10 pending office actions • 3 clients • 10 examiners • 9 art units • 0 of 10 (0%) have an AI response strategy ready

Analysis

Giordano Law LLC specializes in Biotechnology & Pharmaceuticals, having managed 133 career applications in this space. The firm has achieved a resolved allowance rate pct of 77.89. This allowance rate is coupled with an avg office actions per allowance of 3.0, which reflects the level of prosecution required to reach an allowance for their clients in this field.

The firm currently has 9 pending office actions under review. With 133 career applications on record, these 9 pending office actions represent the firm's current workload. The 77.89 resolved allowance rate pct and 3.0 avg office actions per allowance provide a benchmark for the outcomes and effort levels in their Biotechnology & Pharmaceuticals practice. These figures indicate the prosecution environment and the firm's experience in its technology area as it handles these active cases.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=133 apps, methodology: how we score firms)

77.9%
Allowance Rate
n=133
+0.56σ
Allowance Rate (norm)
n=133
3.0
OAs to Allowance
n=74
-0.36σ
OAs to Allow (norm)
n=74
803 days
Time to Allowance
n=74
+30.9pp
Interview Lift
n=133
28.4%
RCE Rate
n=133
2.0%
Appeal Rate
n=133

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=15 (min 20)
52.9%
§102 Overcome
n=34
55.7%
§103 Overcome
n=61
60.9%
§112 Overcome
n=46

Specialization & Scale

A61K, H04M, H04W
Top CPC Subclasses
39%
Top-3 CPC Share
n=133
0
Practitioners
n=133
—
Apps / Practitioner
n=133 (min 20)

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (50%)
4
Medium (40%)
1
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (20%)
§103 only2 (20%)
Double-patenting only1 (10%)
Double-patenting + other2 (20%)
Multi-statute (no §101)3 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
50% of docket
1
Information Tech
10% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
30% of docket
1
Business / Other
10% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUTTER, GILLIAN A 1 54.5% +46.2%
OTTON, ALICIA L 1 64.9% +9.4%
NEAL, ALLISON MICHELLE 1 19.5% +27.0%
BATISTA, MARCOS 1 81.9% +16.4%
LIDDLE, JAY TRENT 1 57.8% +22.9%
LAZARO, DAVID R 1 87.1% +3.7%
HAN, ROBIN 1 33.8% +61.8%
KASSA, TIGABU 1 36.7% +27.9%
KOSTURKO, GEORGE W 1 54.7% +49.0%
KWON, JOHN SEUNGJAI 1 45.7% +19.3%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18786899 Automatic Aftercall Directory And Phonebook Entry Advertising BATISTA, MARCOS —

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18691840 Intrauterine Contraceptive Device HAN, ROBIN 56d
18920156 AUTOMATIC AFTER CALL SURVEY AND CAMPAIGN-BASED CUSTOMER FEEDBACK COLLECTION PLATFORM NEAL, ALLISON MICHELLE —
18707722 SYSTEMS AND METHODS FOR LOTTERY GAME PLAY OVER MOBILE NETWORKS USING A MOBILE ACCOUNT LIDDLE, JAY TRENT —
18707541 METHODS AND SYSTEMS FOR EMOTIVE AND CONTEXTUAL MESSAGING LAZARO, DAVID R —
18032749 ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF KASSA, TIGABU —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18691840 Intrauterine Contraceptive Device HAN, ROBIN 56d
19444750 PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND HUTTER, GILLIAN A —
18920156 AUTOMATIC AFTER CALL SURVEY AND CAMPAIGN-BASED CUSTOMER FEEDBACK COLLECTION PLATFORM NEAL, ALLISON MICHELLE —
18786899 Automatic Aftercall Directory And Phonebook Entry Advertising BATISTA, MARCOS —
18707722 SYSTEMS AND METHODS FOR LOTTERY GAME PLAY OVER MOBILE NETWORKS USING A MOBILE ACCOUNT LIDDLE, JAY TRENT —
18032749 ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF KASSA, TIGABU —
17918386 PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND KOSTURKO, GEORGE W —
17802078 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION KWON, JOHN SEUNGJAI —

Client Portfolio (3 clients)

Client (Assignee)Pending OAs
Kolmar Korea 5
Onepin, Inc. 4
Sebela Vlc Limited 1

Top Art Units

Art UnitApps
16251
16991
36251
37151
24551
37861
16191
16211
16151

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19444750 PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND Hk Inno.N Corporation HUTTER, GILLIAN A 1625 §102§103DP Non-Final OA — Pending Jan 09, 2026
19444665 NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE Hk Inno.N Corporation OTTON, ALICIA L 1699 §102§103DPOther Non-Final OA — Pending Jan 09, 2026
18920156 AUTOMATIC AFTER CALL SURVEY AND CAMPAIGN-BASED CUSTOMER FEEDBACK COLLECTION PLATFORM Onepin, Inc. NEAL, ALLISON MICHELLE 3625 §101DP Non-Final OA — Pending Oct 18, 2024
18786899 Automatic Aftercall Directory And Phonebook Entry Advertising Onepin, Inc. BATISTA, MARCOS DP Non-Final OA — Pending Jul 29, 2024
18707722 SYSTEMS AND METHODS FOR LOTTERY GAME PLAY OVER MOBILE NETWORKS USING A MOBILE ACCOUNT Onepin, Inc. LIDDLE, JAY TRENT 3715 §101§102§103 Non-Final OA — Pending May 06, 2024
18707541 METHODS AND SYSTEMS FOR EMOTIVE AND CONTEXTUAL MESSAGING Onepin, Inc. LAZARO, DAVID R 2455 §102§103§112 Non-Final OA — Pending May 03, 2024
18691840 Intrauterine Contraceptive Device Sebela Vlc Limited HAN, ROBIN 3786 §103§112 Final Rejection 56d Pending Mar 13, 2024
18032749 ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF Hk Inno.N Corporation KASSA, TIGABU 1619 §103§112 Final Rejection — Pending Apr 19, 2023
17918386 PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND Hk Inno.N Corporation KOSTURKO, GEORGE W 1621 §103 Final Rejection — Pending Mar 27, 2023
17802078 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION Hk Inno. N Corporation KWON, JOHN SEUNGJAI 1615 §103 Non-Final OA — Pending Aug 24, 2022

Managing Giordano Law LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month